Eight years ofpersonal experience of long-acting isoprenaline in the treatment of chronic complete heart block is described. In selected patients the long-term results can 
In I963 this Unit reported the use of longacting isoprenaline (Saventrine) in the treatment of complete heart block in 8 patients (Fleming and Mirams, I963) . Two of these had died before the report was published; 4 of the remaining 6 survive and are in good health at the time of writing 8 years later. This is a better result than might have been anticipated with the pacemakers available in I962-63 in this region. Since then pacemakers and their problems have vastly improved and there is now a tendency to pace most patients with bradycardia. However, our own experience with long-acting isoprenaline has continued to be satisfactory in selected patients, and similar findings have been reported by Bluestone and Harris (i965) , El-Nahas and Johnson (i966), and Redwood (I969).
We felt that the time had now come to review briefly our own experience with Saventrine to date.
Subjects
We first present the 8 cases -the subject of the original report (Table) .
Comment
In the individual patient the dose has varied from time to time and patients have needed a good deal of attention to detail to establish precisely the regimen which suited them best. This is not only essential to establish an adequate therapeutic effect but often to avoid important side effects.
Case i who has been on treatment for nearly 8 These results show that approximately half the patients who have been treated with isoprenaline have done well. This proportion has been greatly increased since the intravenous isoprenaline infusion test was introduced. The introduction of simpler pacing systems in this region (Clarke, Evans, and Milstein, I97I) has extended the scope of long-term pacing but the authors feel that medical treatment still has a small but definite place. The economics of pacing (Whitaker, I970) make it unlikely that with present methods (Sowton, I968) all patients who might benefit can be fitted into a reliable service and, in some areas at least, drug treatment will continue to have a place in the management of the problem. Our feelings on the selection of cases are in agreement with those stated by Redwood (I969) . Attention to the detail of the regimen and the timing, as well as the amount of the dose, is most important in the individual patient.
